Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Päätekijät: Rachel S Laufer (Tekijä), Ranju Baral (Tekijä), Andrea G Buchwald (Tekijä), James D Campbell (Tekijä), Flanon Coulibaly (Tekijä), Fatoumata Diallo (Tekijä), Moussa Doumbia (Tekijä), Amanda J Driscoll (Tekijä), Alison P Galvani (Tekijä), Adama M Keita (Tekijä), Kathleen M Neuzil (Tekijä), Samba Sow (Tekijä), Clint Pecenka (Tekijä), Justin R Ortiz (Tekijä), Meagan C Fitzpatrick (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...